Medical condition
Glaucoma
Glaucoma is a medical condition tracked by NovaPharmaNews across 6 associated drugs and ongoing industry coverage. Explore approved and pipeline therapies, regulatory status, and the latest developments.
Associated drugs & therapies
- bimatoprost (BIMATOPROST SANDOZ) Sensory organs (S01)
- netarsudil (RHOKIINSA) Sensory organs (S01)
- brinzolamide (AZOPT) Sensory organs (S01)
- latanoprost (APO-LATANOPROST) Sensory organs (S01)
- travoprost (TRAVATAN) Sensory organs (S01)
- latanoprost / netarsudil (ROCLANDA) Sensory organs (S01)
Latest Glaucoma news
Spinogenix Tazbentetol Shows Neuroprotective Effects in Glaucoma and Diabetic Retinopathy Preclinical Studies at ARVO 2026
Spinogenix presents preclinical data showing Tazbentetol (SPG302) reduces retinal cell loss and preserves visual function in eye disease models at ARVO 2026.
FDA Approves OptiSight: New VisionCare Glaucoma Treatment
The FDA has officially approved OptiSight, a novel treatment for glaucoma, promising enhanced vision care and improved outcomes for patients.